| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.5M | +36.1% |
| Cost of Revenue | $4.2M | +44.6% |
| R&D Expense | $301.3M | +1.9% |
| SG&A Expense | $156.8M | +30.8% |
| Operating Income | -$425.7M | -8.7% |
| Pre-tax Income | $718.0M | +303.9% |
| Income Tax | $44.2M | — |
| Net Income | $673.7M | +291.4% |
| EPS (Basic) | $11.86 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.2M | -13.6% |
| Inventory | $27.6M | +44.8% |
| Current Assets | $965.6M | +15.8% |
| Total Assets | $1.66B | +77.5% |
| Current Liabilities | $81.2M | +19.4% |
| Total Liabilities | $122.2M | -3.1% |
| Stockholders' Equity | $1.54B | +90.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$389.8M | -31.7% |
| Capital Expenditures | $1.7M | +68.7% |
| Investing Cash Flow | $363.4M | +51.7% |
| Financing Cash Flow | $14.4M | +165.8% |
| Free Cash Flow | -$391.5M | -31.8% |
| +287.4% |
| EPS (Diluted) | $11.64 | +283.9% |